Cargando…
A Novel Immune-Related ceRNA Network and Relative Potential Therapeutic Drug Prediction in ccRCC
Renal cell carcinoma (RCC) is the third common solid tumor in the urinary system with a high distant metastasis rate. The five-year survival rate of RCC has reached 75%, benefiting from the emergence and update of multiple treatments, while its pathogenesis and prognostic markers are still unclear....
Autores principales: | Li, Weiquan, Meng, Xiangui, Yuan, Hongwei, Xiao, Wen, Zhang, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821820/ https://www.ncbi.nlm.nih.gov/pubmed/35145542 http://dx.doi.org/10.3389/fgene.2021.755706 |
Ejemplares similares
-
The Downregulation of Prognosis- and Immune Infiltration-Related Gene CYFIP2 Serves as a Novel Target in ccRCC
por: Tong, Junwei, et al.
Publicado: (2021) -
Pivotal biomarker expression and drug screening in advanced ccRCC
por: Xiao, Wen, et al.
Publicado: (2020) -
Untangling ccRCC prognosis with SLINKY
por: Reinfeld, Bradley I., et al.
Publicado: (2017) -
Role of copper ionophore–induced death in immune microenvironment and clinical prognosis of ccRCC: An integrated analysis
por: Xia, Shunyao, et al.
Publicado: (2022) -
Cuproptosis in ccRCC: key player in therapeutic and prognostic targets
por: Lv, Yang, et al.
Publicado: (2023)